Thomas Shrader, Ph.D. - Vice President, Communications & Strategy
Dr. Shrader joined Intrexon Corporation in January 2018 as Vice President, Communications & Strategy. Most recently he was a Managing Director in Stifel’s Healthcare sector covering Biotechnology. Before joining Stifel, Dr. Shrader was the Director of Strategic Corporate Partnerships at Yale University and spent a decade as a sell-side analyst, principally at BMO Capital Markets and its predecessors. His past awards include the Wall Street Journal’s Best on the Street Survey Award. Dr. Shrader has also been an associate and assistant professor of biochemistry at the Albert Einstein College of Medicine (AECOM) where he directed a laboratory focused on infectious diseases drug target discovery. While at AECOM, he served as an external grant reviewer for the NIH and was a member of the board of reviewers for a number of journals, including The Journal of Biological Chemistry, Trends in Microbiology, and Genes & Development. Dr. Shrader was a Helen Hay Whitney Fellow at the Massachusetts Institute of Technology, earned a Ph.D. in Molecular Biophysics and Biochemistry from Yale University, and a Bachelor of Arts and Sciences degree in Biophysics from The Johns Hopkins University.